{"id":"W2275672421","doi":"10.1016/j.ahj.2016.01.004","title":"A randomized trial to compare the safety of rivaroxaban vs aspirin in addition to either clopidogrel or ticagrelor in acute coronary syndrome: The design of the GEMINI-ACS-1 phase II study","year":2016,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"Janssen Research and Development; Bayer HealthCare","keywords":"Medicine; Ticagrelor; Clopidogrel; Acute coronary syndrome; TIMI; Rivaroxaban; Prasugrel; Aspirin; P2Y12; Internal medicine; Myocardial infarction; Cardiology; Atrial fibrillation; Percutaneous coronary intervention; Warfarin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004056084,0.003169175,0.005261489,0.0005839919,0.0005280159,0.001899626,0.00123688,0.003083449,0.007920769],"category_scores_gemma":[0.004761177,0.001106907,0.003442577,0.0005523199,0.001593361,0.002006681,0.0008672457,0.004727196,0.001801096],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009497934,"about_ca_system_score_gemma":0.001352219,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00088868,"about_ca_topic_score_gemma":0.001231792,"domain_scores_codex":[0.9977828,0.001338275,0.0001134873,0.0003999036,0.0001338531,0.0002317552],"domain_scores_gemma":[0.9974044,0.0008306619,0.0005732384,0.0002899205,0.0001768318,0.0007249605],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.994328,0.001855923,0.0002850347,0.0001308608,0.0006062902,0.00001996576,0.0000147424,0.0001145396,0.0004236166,0.00008170362,0.0003086867,0.001830658],"study_design_scores_gemma":[0.9791436,0.01909206,0.000584438,0.00001218553,0.0004334511,0.00001548564,0.000007257106,0.0002794064,0.00006100077,0.0001246441,0.0002378643,0.000008519053],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"protocol","genre_scores_codex":[0.9733189,0.005327069,0.001565746,0.002315619,0.002724366,0.008279769,0.002313125,0.0002327813,0.003922725],"genre_scores_gemma":[0.9664062,0.002793658,0.003926087,0.003983622,0.002339303,0.01076657,0.003622423,0.00007251589,0.006089507],"genre_candidate":"protocol","genre_consensus":null,"teacher_disagreement_score":0.007920769,"threshold_uncertainty_score":0.0264976,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03387865630729978,"score_gpt":0.3326836934123949,"score_spread":0.2988050371050951,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}